| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.061 | 0.3 |